Overview
Carl Glittenberg practices in Vienna, Austria. Mr. Glittenberg is rated as an Experienced expert by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Central Serous Chorioretinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), and Vitrectomy.
His clinical research consists of co-authoring 30 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Central Serous Chorioretinopathy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- VitrectomyMr. Glittenberg isAdvanced. Learn about Vitrectomy.
- Experienced
- Adult-Onset Vitelliform Macular Dystrophy (AVMD)Mr. Glittenberg isExperienced. Learn about Adult-Onset Vitelliform Macular Dystrophy (AVMD).
- Age-Related Macular Degeneration (ARMD)Mr. Glittenberg isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- Central Serous ChorioretinopathyMr. Glittenberg isExperienced. Learn about Central Serous Chorioretinopathy.
- Diabetic Macular Edema (DME)Mr. Glittenberg isExperienced. Learn about Diabetic Macular Edema (DME).
- Diabetic RetinopathyMr. Glittenberg isExperienced. Learn about Diabetic Retinopathy.
- Late-Onset Retinal DegenerationMr. Glittenberg isExperienced. Learn about Late-Onset Retinal Degeneration.